IMP-11

N/A

Report date: 2024/05/31 15:43:06
NME

Base Information

Drug NameIMP-11
Drug Alias NameIMP-11IMP11
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA activated protein kinases inhibitors
TargetsDNA activated protein kinases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Impact Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Impact Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A